1. P236 Baricitinib provides better pain relief across all disease activity levels compared with placebo and adalimumab in RA. (20th April 2020) Authors: Taylor (Presenter), Peter C; Pope, Janet; Ikeda, Kei; Zhang, Xiang; Jia, Bochao; Zhang, Hong; Quebe, Amanda; Chen, Yun-Fei; Kannowski, Carol L; Holzkaemper, Thorsten; Cardoso, Anabela; Sebba, Anthony Journal: Rheumatology Issue: Volume 59(2020)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗